Alzheimer's Disease: Potential Benefit of Isoflavones
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this pilot study is to evaluate the potential effects of soy isoflavone
supplements on cognitive function for men and women with Alzheimer's Disease (AD).
Preliminary studies evaluating the effects of soy supplements on memory in cognitively
healthy older adults have yielded promising results that are now being evaluated in patients
with AD. It is hypothesized that isoflavone supplements will ameliorate cognitive declines
for older adults diagnosed with Alzheimer's disease, when compared to subjects on placebo.
Phase:
Phase 2
Details
Lead Sponsor:
University of Wisconsin, Madison
Collaborators:
National Institute on Aging (NIA) National Institutes of Health (NIH)